Ron Bentsur - 28 Mar 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
28 Mar 2022
Net transactions value
+$28,200
Form type
4
Filing time
29 Mar 2022, 08:31:50 UTC
Previous filing
18 Mar 2022
Next filing
05 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock, par value $0.00001 Purchase $28,200 +4,000 +0.14% $7.05 2,825,459 28 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 96,759 shares of restricted stock.